These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 7743604

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of tissue factor in the antitumor effect of recombinant human tumor necrosis factor-alpha in mice.
    Nishigaki F, Miyayasu K, Tsujimoto S, Manda T, Shimomura K.
    Anticancer Res; 1994; 14(6B):2573-6. PubMed ID: 7872683
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. TNF induces endogenous TNF in vivo: the basis of EET therapy as a combination of rTNF together with endogenous TNF.
    Inagawa H, Oshima H, Soma G, Mizuno D.
    J Biol Response Mod; 1988 Dec; 7(6):596-607. PubMed ID: 3216223
    [Abstract] [Full Text] [Related]

  • 9. [Induction of tumor necrosis factor (TNF) in tumor-bearing mice].
    Tamura K, Ishida N.
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1369-78. PubMed ID: 6378101
    [Abstract] [Full Text] [Related]

  • 10. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
    Furrer M, Altermatt HJ, Ris HB, Althaus U, Rüegg C, Liénard D, Lejeune FJ.
    Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
    [Abstract] [Full Text] [Related]

  • 11. Differences in the bioactivity of recombinant human TNF, LT, and T-cell-derived LT-3 on transformed cells in vitro and the Meth A tumor growing in BALB/c mice.
    Granger GA, Masunaka I, Averbook B, Kobayashi M, Fitzgerald M, Yamamoto R.
    J Biol Response Mod; 1988 Oct; 7(5):488-97. PubMed ID: 3263472
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus.
    Gnant MF, Berger AC, Huang J, Puhlmann M, Wu PC, Merino MJ, Bartlett DL, Alexander HR, Libutti SK.
    Cancer Res; 1999 Sep 15; 59(18):4668-74. PubMed ID: 10493523
    [Abstract] [Full Text] [Related]

  • 17. In vitro remodeling of tumor vascular endothelial cells using conditioned medium from various tumor cells and their sensitivity to TNF-alpha.
    Kamada H, Tsutsumi Y, Kihira T, Tsunoda S, Yamamoto Y, Mayumi T.
    Biochem Biophys Res Commun; 2000 Feb 24; 268(3):809-13. PubMed ID: 10679287
    [Abstract] [Full Text] [Related]

  • 18. In vivo analysis of the 'bystander effect': a cytokine cascade.
    Ramesh R, Marrogi AJ, Munshi A, Abboud CN, Freeman SM.
    Exp Hematol; 1996 Jun 24; 24(7):829-38. PubMed ID: 8647234
    [Abstract] [Full Text] [Related]

  • 19. [Establishment of double grafted tumor model in mice and role of "tumor necrosis factor" (TNF)].
    Kita M, Sakata K, Imanishi J.
    C R Seances Soc Biol Fil; 1991 Jun 24; 185(5):370-4. PubMed ID: 1806196
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms by which chemotherapeutic agents augment the antitumor effects of tumor necrosis factor: involvement of the pattern shift of cytokines from Th2 to Th1 in tumor lesions.
    Inagawa H, Nishizawa T, Honda T, Nakamoto T, Takagi K, Soma G.
    Anticancer Res; 1998 Jun 24; 18(5D):3957-64. PubMed ID: 9854510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.